journal article·2023-02-27Open access

Biodegradable Cements for Bone Regeneration

Dachuan Liu, Chen Cui, Weicheng Chen, Jiaxu Shi, Bin Li, Song Chen

Abstract

Bone cements such as polymethyl methacrylate and calcium phosphates have been widely used for the reconstruction of bone. Despite their remarkable clinical success, the low degradation rate of these materials hampers a broader clinical use. Matching the degradation rate of the materials with neo bone formation remains a challenge for bone-repairing materials. Moreover, questions such as the mechanism of degradation and how the composition of the materials contribute to the degradation property remain unanswered. Therefore, the review provides an overview of currently used biodegradable bone cements such as calcium phosphates (CaP), calcium sulfates and organic-inorganic composites. The possible degradation mechanism and clinical performance of the biodegradable cements are summarized. This paper reviews up-to-date research and applications of biodegradable cements, hoping to provide researchers in the field with inspirations and references.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Facial Trauma and Fracture Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopaedic Surgery, Orthopaedic Institute, The First Affiliated Hospital, Suzhou Medical College, Soochow University, Suzhou 215006, China

Department of Orthopaedic Surgery, The Third Affiliated Hospital of Soochow University, 185 Ju Qian Road, Changzhou 213003, China

Funding

National Natural Science Foundation of China · Priority Academic Program Development of Jiangsu Higher Education Institutions

References (100+)

Show source-provided references
1. Xue, N., Ding, X., Huang, R., Jiang, R., Huang, H., Pan, X., Min, W., Chen, J., Duan, J.A., and Liu, P. (2022). Bone Tissue Engineering in the Treatment of Bone Defects. Pharmaceuticals, 15.10.3390/ph15070879 ↗
2. Current state of fabrication technologies and materials for bone tissue engineering10.1016/j.actbio.2018.09.031 ↗
3. Construction of biomimetic cell-sheet-engineered periosteum with a double cell sheet to repair calvarial defects of rats10.1016/j.jot.2022.09.005 ↗
4. A novel tissue-engineered bone graft composed of silicon-substituted calcium phosphate, autogenous fine particulate bone powder and BMSCs promotes posterolateral spinal fusion in rabbits10.1016/j.jot.2020.06.003 ↗
5. Immobilization of bioactive vascular endothelial growth factor onto Ca-deficient hydroxyapatite-coated Mg by covalent bonding using polydopamine10.1016/j.jot.2021.06.002 ↗
6. Manufacturing artificial bone allografts: A perspective
7. Materials design for bone-tissue engineering10.1038/s41578-020-0204-2 ↗
8. Bone regeneration: Current concepts and future directions10.1186/1741-7015-9-66 ↗
9. Jimenez-Marcos, C., Mirza-Rosca, J.C., Baltatu, M.S., and Vizureanu, P. (2022). Experimental Research on New Developed Titanium Alloys for Biomedical Applications. Bioengineering, 9.10.3390/bioengineering9110686 ↗
10. Baltatu, M.S., Spataru, M.C., Verestiuc, L., Balan, V., Solcan, C., Sandu, A.V., Geanta, V., Voiculescu, I., and Vizureanu, P. (2021). Design, Synthesis, and Preliminary Evaluation for Ti-Mo-Zr-Ta-Si Alloys for Potential Implant Applications. Materials, 14.10.3390/ma14226806 ↗
11. Calcium phosphate cements: Optimization toward biodegradability10.1016/j.actbio.2020.10.013 ↗
12. Novel injectable strontium-hardystonite phosphate cement for cancellous bone filling applications10.1016/j.msec.2018.11.069 ↗
13. Bone Cement Implantation Syndrome: Incidence and Associated Factors in a United States Setting
14. Pulmonary cement embolism after percutaneous vertebroplasty in osteoporotic vertebral compression fractures: Incidence, characteristics, and risk factors10.1148/radiol.2511080854 ↗
15. Design of biodegradable, implantable devices towards clinical translation10.1038/s41578-019-0150-z ↗
16. Biodegradable polymers as biomaterials10.1163/156856295X00175 ↗
17. Endogenous repair theory enriches construction strategies for orthopaedic biomaterials: A narrative review
18. Advances in osteobiologic materials for bone substitutes10.1002/term.2677 ↗
19. Biodegradable materials for bone defect repair
20. Control of in vivo mineral bone cement degradation10.1016/j.actbio.2014.04.020 ↗
21. Bioabsorbable implants in forefoot surgery: A review of materials, possibilities and disadvantages10.1302/2058-5241.6.200157 ↗
22. In vitro and in vivo degradation assessment and preventive measures of biodegradable Mg alloys for biomedical applications10.1002/jbm.a.37297 ↗
23. In Vitro Bioactivity Assessment of Metallic Magnesium
24. Monetite, an important calcium phosphate compound-Its synthesis, properties and applications in orthopedics10.1016/j.actbio.2021.03.050 ↗
25. Ion-doped Brushite Cements for Bone Regeneration10.1016/j.actbio.2021.01.004 ↗
26. Biodegradable Materials for Bone Repair and Tissue Engineering Applications10.3390/ma8095273 ↗
27. Biological and mechanical performance and degradation characteristics of calcium phosphate cements in large animals and humans10.1016/j.actbio.2020.09.031 ↗
28. Injectable and fast resorbable calcium phosphate cement for body-setting bone grafts10.1007/s10856-010-4078-5 ↗
29. Calcium phosphate cements for bone engineering and their biological properties10.1038/boneres.2017.56 ↗
30. In vivo behavior of three different injectable hydraulic calcium phosphate cements10.1016/j.biomaterials.2003.08.073 ↗
31. Calcium orthophosphates in medicine: From ceramics to calcium phosphate cements10.1016/S0020-1383(00)80022-4 ↗
32. Tissue response to fast-setting calcium phosphate cement in bone10.1002/(SICI)1097-4636(19971215)37:4<457::AID-JBM3>3.0.CO;2-K ↗
33. Calcium phosphate cements as drug delivery materials10.1016/j.addr.2012.01.008 ↗
34. Calcium phosphate bone cements for clinical applications10.1023/A:1008937507714 ↗
35. Long-term evaluation of the degradation behavior of three apatite-forming calcium phosphate cements10.1002/jbm.a.35641 ↗
36. Dicalcium phosphate cements: Brushite and monetite10.1016/j.actbio.2011.08.005 ↗
37. The in vitro evolution of resorbable brushite cements: A physico-chemical, micro-structural and mechanical study10.1016/j.actbio.2017.02.023 ↗
38. Biological and Medical Significance of Calcium Phosphates10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1 ↗
39. Volume effect on biological properties of a calcium phosphate hydraulic cement: Experimental study in sheep10.1016/S8756-3282(99)00147-7 ↗
40. A new method to produce macropores in calcium phosphate cements10.1016/S0142-9612(02)00101-1 ↗
41. In vivo bone response to porous calcium phosphate cement
42. In vitro degradation rate of apatitic calcium phosphate cement with incorporated PLGA microspheres10.1016/j.actbio.2011.05.036 ↗
43. Bone response to fast-degrading, injectable calcium phosphate cements containing PLGA microparticles10.1016/j.biomaterials.2011.08.005 ↗
44. Macrophages, Foreign Body Giant Cells and Their Response to Implantable Biomaterials10.3390/ma8095269 ↗
45. Biocompatibility and resorption of a brushite calcium phosphate cement10.1016/j.biomaterials.2004.11.056 ↗
46. The effect of amorphous pyrophosphate on calcium phosphate cement resorption and bone generation10.1016/j.biomaterials.2013.05.001 ↗
47. The effect of autoclaving on the physical and biological properties of dicalcium phosphate dihydrate bioceramics: Brushite vs. monetite10.1016/j.actbio.2012.04.025 ↗
48. Resorption of monetite granules in alveolar bone defects in human patients10.1016/j.biomaterials.2009.12.039 ↗
49. Monetite granules versus particulate autologous bone in bone regeneration10.1016/j.aanat.2015.03.008 ↗
50. In vitro degradation and in vivo resorption of dicalcium phosphate cement based grafts10.1016/j.actbio.2015.08.031 ↗
51. Effect of processing conditions of dicalcium phosphate cements on graft resorption and bone formation10.1016/j.actbio.2017.02.022 ↗
52. Monetite-based composite cranial implants demonstrate long-term clinical volumetric balance by concomitant bone formation and degradation10.1016/j.actbio.2021.04.015 ↗
53. Calcium sulfate: Properties and clinical applications10.1002/jbm.b.31269 ↗
54. Bohner, M. (2008). Degradation Rate of Bioresorbable Materials, Woodhead Publishing.10.1533/9781845695033.2.95 ↗
55. Self-setting properties and in vitro bioactivity of calcium sulfate hemihydrate-tricalcium silicate composite bone cements10.1016/j.actbio.2007.05.003 ↗
56. Medical-grade calcium sulfate hemihydrate in clinical implant dentistry: A review10.1615/JLongTermEffMedImplants.v20.i4.40 ↗
58. Calcium sulfates: What is the evidence?10.1097/BOT.0b013e3181cec48e ↗
59. The implantation of plaster of paris in the alveolar process of the dog10.1902/jop.1965.36.5.357 ↗
60. Treatment of benign bone lesions with an injectable calcium sulfate-based bone graft substitute10.3928/0147-7447-20040102-11 ↗
61. Study on injectable and degradable cement of calcium sulphate and calcium phosphate for bone repair10.1007/s10856-009-3885-z ↗
62. Altered bioreactivity and limited osteoconductivity of calcium sulfate-based bone cements in the osteoporotic rat spine10.1016/j.spinee.2007.06.003 ↗
63. Ceramic Biocomposites as Biodegradable Antibiotic Carriers in the Treatment of Bone Infections10.7150/jbji.17234 ↗
64. Evaluation of four biodegradable, injectable bone cements in an experimental drill hole model in sheep10.1016/j.ejpb.2013.04.013 ↗
65. Improving biodegradation behavior of calcium sulfate bone graft tablet by using water vapor treatment10.1016/j.msec.2012.08.016 ↗
66. Organic-Inorganic Composites Toward Biomaterial Application10.1159/000381691 ↗
67. Biodegradable inorganic-organic hybrids of methacrylate star polymers for bone regeneration10.1016/j.actbio.2017.03.008 ↗
68. Bone tissue engineering: State of the art and future trends10.1002/mabi.200400026 ↗
69. Porcine gelatin microsphere/calcium phosphate cement composites: An in vitro degradation study10.1002/jbm.b.31429 ↗
70. Long-term variations in mechanical properties and in vivo degradability of CPC/PLGA composite10.1002/jbm.b.30759 ↗
71. Novel, degradable, and cytoactive bone cements based on magnesium polyphosphate and calcium citrate10.1039/D2NJ01706G ↗
72. The biodegradation mechanism of calcium phosphate biomaterials in bone10.1002/jbm.10259 ↗
73. Calcium phosphate cement: Review of mechanical and biological properties10.1111/j.1532-849X.2006.00129.x ↗
74. A head-to-head comparison of the degradation rate of resorbable bioceramics10.1016/j.msec.2019.110175 ↗
75. Calcium sulfate as bone graft substitute in the treatment of osseous bone defects, a prospective study
76. In vitro biodegradation of three brushite calcium phosphate cements by a macrophage cell-line10.1016/j.biomaterials.2006.04.030 ↗
77. Hydroxyapatite-polymer biocomposites for bone regeneration: A review of current trends10.1002/jbm.b.33950 ↗
78. Bioresorbability, porosity and mechanical strength of bone substitutes: What is optimal for bone regeneration?10.1016/j.injury.2011.06.008 ↗
79. Ingham, E., Green. T.R., Stone. M.H., Kowalski. R., Watkins. N., and Fisher, J (2000). Production of TNF-alpha and bone resorbing activity by macrophages in response to different types of bone cement particles. Biomaterials, 99, 1005–1013.10.1016/S0142-9612(99)00261-6 ↗
80. Biodegradable Bone Regeneration Synthetic Scaffolds: In Tissue Engineering10.2174/157488812799219018 ↗
81. Resorption of, and bone formation from, new beta-tricalcium phosphate-monocalcium phosphate cements: An in vivo study10.1002/(SICI)1097-4636(199602)30:2<193::AID-JBM9>3.0.CO;2-M ↗
82. Use of Gastrointestinal Proton Pump Inhibitors to Regulate Osteoclast Mediated Resorption of Calcium Phosphate Cements In Vivo10.2174/156720109787846225 ↗
83. Osteoclastic bioresorption of biomaterials: Two- and three-dimensional imaging and quantification10.1177/039139881003300404 ↗
84. Passive and active in vitro resorption of calcium and magnesium phosphate cements by osteoclastic cells10.1089/ten.tea.2010.0281 ↗
85. Bernhardt, A., Schamel, M., Gbureck, U., and Gelinsky, M. (2017). Osteoclastic differentiation and resorption is modulated by bioactive metal ions Co2+, Cu2+ and Cr3+ incorporated into calcium phosphate bone cements. PLoS ONE, 12.10.1371/journal.pone.0182109 ↗
86. Trivalent chromium incorporated in a crystalline calcium phosphate matrix accelerates materials degradation and bone formation in vivo10.1016/j.actbio.2018.01.010 ↗
87. Strontium substitution in apatitic CaP cements effectively attenuates osteoclastic resorption but does not inhibit osteoclastogenesis10.1016/j.actbio.2016.04.016 ↗
88. Biodegradation of Tricalcium Phosphate Ceramics by Osteoclasts10.1007/BF02886487 ↗
89. Visualising phase change in a brushite-based calcium phosphate ceramic10.1038/srep32671 ↗
90. Raman microspectrometry studies of brushite cement: In vivo evolution in a sheep model10.1016/S8756-3282(99)00139-8 ↗
91. High-strength calcium silicate-incorporated magnesium phosphate bone cement with osteogenic potential for orthopedic application10.1016/j.compositesb.2022.110324 ↗
92. How useful is SBF in predicting in vivo bone bioactivity?10.1016/j.biomaterials.2006.01.017 ↗
93. Balloon kyphoplasty of vertebral compression fractures with a new calcium phosphate cement10.1007/s00132-003-0578-z ↗
94. CT volumetry of intravertebral cement after kyphoplasty. Comparison of polymethylmethacrylate and calcium phosphate in a 12-month follow-up10.1007/s00330-005-2709-x ↗
95. Morphological changes of injected calcium phosphate cement in osteoporotic compressed vertebral bodies10.1007/s00198-009-0911-4 ↗
96. Subchondral defects in caprine femora augmented with in situ setting hydroxyapatite cement, polymethylmethacrylate, or autogenous bone graft: Biomechanical and histomorphological analysis after two-years10.1016/S0736-0266(01)00124-3 ↗
97. Calcium phosphate cements for bone substitution: Chemistry, handling and mechanical properties10.1016/j.actbio.2013.11.001 ↗
98. Histological and mechanical evaluation of self-setting calcium phosphate cements in a sheep vertebral bone void model10.1002/jbm.a.31079 ↗
99. Tricalcium phosphate as an adjunct to apical closure in pulpless permanent teeth10.1016/S0099-2399(75)80038-0 ↗
100. Hydroxyapatite cement: A new method for achieving watertight closure in transtemporal surgery